Publication | Open Access
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
80
Citations
19
References
2022
Year
Empagliflozin reduced the incidence of hyperkalaemia without significant increase in hypokalaemia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1